Last reviewed · How we verify

NCT06218160

The Addition of Hydromorphone to Local Anesthetics for the Repair of Inguinal Hernias in Elderly Patients

Completed NA Last updated 23 January 2024
What this trial tests

NA trial testing Hydromorphone combined with ropivacaine in Inguinal Hernia in 63 participants. Completed in 25 December 2023.

Timeline
1 November 2022
Primary endpoint
30 November 2023
25 December 2023

Quick facts

Lead sponsorSecond Hospital of Jilin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment63
Start date1 November 2022
Primary completion30 November 2023
Estimated completion25 December 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Second Hospital of Jilin University

Who can join

60 and older, any sex, with Inguinal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the clinical and postoperative analgesic effects of hydromorphone combined with ropivacaine and ropivacaine alone in quadrangular muscle block for open inguinal hernia in elderly patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other Second Hospital of Jilin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06218160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing